Literature DB >> 11908643

Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides.

Hans J Vogel1, David J Schibli, Weiguo Jing, Elke M Lohmeier-Vogel, Raquel F Epand, Richard M Epand.   

Abstract

The iron-binding protein lactoferrin is a multifunctional protein that has antibacterial, antifungal, antiviral, antitumour, anti-inflammatory, and immunoregulatory properties. All of these additional properties appear to be related to its highly basic N-terminal region. This part of the protein can be released in the stomach by pepsin cleavage at acid pH. The 25-residue antimicrobial peptide that is released is called lactoferricin. In this work, we review our knowledge about the structure of the peptide and attempt to relate this to its many functions. Microcalorimetry and fluorescence spectroscopy data regarding the interaction of the peptide with model membranes show that binding to net negatively charged bacterial and cancer cell membranes is preferred over neutral eukaryotic membranes. Binding of the peptide destabilizes the regular membrane bilayer structure. Residues that are of particular importance for the activity of lactoferricin are tryptophan and arginine. These two amino acids are also prevalent in "penetratins", which are regions of proteins or synthetic peptides that can spontaneously cross membranes and in short hexapeptide antimicrobial peptides derived through combinatorial chemistry. While the antimicrobial, antifungal, antitumour, and antiviral properties of lactoferricin can be related to the Trp/Arg-rich portion of the peptide, we suggest that the anti-inflammatory and immunomodulating properties are more related to a positively charged region of the molecule, which, like the alpha- and beta-defensins, may act as a chemokine. Few small peptides are involved in as wide a range of host defense functions as bovine and human lactoferricin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908643     DOI: 10.1139/o01-213

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  51 in total

1.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

2.  Cyclic Tritrpticin Analogs with Distinct Biological Activities.

Authors:  Leonard T Nguyen; Johnny K Chau; Sebastian A J Zaat; Hans J Vogel
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

3.  Liposome reconstitution of a minimal protein-mediated membrane fusion machine.

Authors:  Deniz Top; Roberto de Antueno; Jayme Salsman; Jennifer Corcoran; Jamie Mader; David Hoskin; Ahmed Touhami; Manfred H Jericho; Roy Duncan
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

4.  Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures.

Authors:  David J Schibli; Leonard T Nguyen; Stephanie D Kernaghan; Øystein Rekdal; Hans J Vogel
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

5.  De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.

Authors:  Berthony Deslouches; Shruti M Phadke; Vanja Lazarevic; Michael Cascio; Kazi Islam; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Evolution of the genetic code by incorporation of amino acids that improved or changed protein function.

Authors:  Brian R Francis
Journal:  J Mol Evol       Date:  2013-06-07       Impact factor: 2.395

7.  Lactoferrin regulates an axis involving CD11b and CD49d integrins and the chemokines MIP-1α and MCP-1 in GM-CSF-treated human primary eosinophils.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Interferon Cytokine Res       Date:  2012-06-25       Impact factor: 2.607

8.  Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.

Authors:  Howard N Hunter; A Ross Demcoe; Håvard Jenssen; Tore J Gutteberg; Hans J Vogel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

9.  Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Authors:  Berthony Deslouches; Kazi Islam; Jodi K Craigo; Shruti M Paranjape; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

10.  Effects of Rationally Designed Physico-Chemical Variants of the Peptide PuroA on Biocidal Activity towards Bacterial and Mammalian Cells.

Authors:  Nadin Shagaghi; Andrew H A Clayton; Marie-Isabel Aguilar; Tzong-Hsien Lee; Enzo A Palombo; Mrinal Bhave
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.